Survival of patients with clinically identified monoclonal B-cell lymphocytosis (MBL) relative to the age-and sex-matched general population

Leukemia

Volumn 26, Issue 2, 2012, Pages 373-376

  Shanafelt, T D ^a   Kay, N E ^a   Rabe, K G ^a   Call, T G ^a   Zent, C S ^a   Schwager, S M ^a   Leis, J F ^b   Jelinek, D F ^c   Slager, S L ^a   Hanson, C A ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; B LYMPHOCYTE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOPHENOTYPING; LETTER; LYMPHADENOPATHY; LYMPHOCYTE COUNT; LYMPHOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MONOCLONAL B CELL LYMPHOCYTOSIS; POPULATION; PRIORITY JOURNAL; SEX RATIO; SURVIVAL; SURVIVAL TIME; TREATMENT FREE SURVIVAL;

AGE FACTORS; AGED; FEMALE; HUMANS; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; SEX FACTORS;

EID: 84856701652     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2011.211     Document Type: Letter

References (12)

1. Rawstron A, Green M, Kuzmicki A, Kennedy B, Fenton J, Evans P et al. Monoclonal B lymphocytes with the characteristics of 'indolent' chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts. Blood 2002; 100: 635-639. (Pubitemid 34761129)
2. Marti GE, Rawstron AC, Ghia P, Hillmen P, Houlston RS, Kay N et al. Diagnostic criteria for monoclonal B-cell lymphocytosis. Br J Haematol 2005; 130: 325-332. (Pubitemid 43899581)
3. Landgren O, Albitar M, Ma W, Abbasi F, Hayes RB, Ghia P et al. B-cell clones as early markers for chronic lymphocytic leukemia. N Engl J Med 2009; 360: 659-667.
4. Shanafelt TD, Kay NE, Jenkins G, Call TG, Zent CS, Jelinek DF et al. B-cell count and survival: differentiating chronic lymphocytic leukemia (CLL) from monoclonal B-cell lymphocytosis (MBL) based on clinical outcome. Blood 2009; 113: 4188-4196.
5. Molica S, Mauro FR, Giannarelli D, Lauria F, Cortelezzi A, Brugiatelli M et al. Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome: on behalf of the GIMEMA chronic lymphoproliferative diseases working group. Haematologica 2011; 96: 277-283.
6. Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Dohner H et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 2008; 111: 5446-5456.
7. Rawstron AC, Shanafelt T, Lanasa MC, Landgren O, Hanson C, Orfao A et al. Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL). Cytometry B Clin Cytom 2010; 78: S19-S23.
8. Shanafelt T, Kay N, Rabe K, Call T, Zent CS, Maddocks K et al. Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis (MBL) compared to patients with Rai 0 chronic lymphocytic leukemia (CLL). J Clin Oncol 2009; 27: 3959-3963.
9. Bennet FL, Dalal S, Jack AS, Hillmen P, Rawstron AC. Five-year follow-up of monoclonal b-cell lymphocytosis (MBL) in individauls with a normal blood count: expansion of the abnormal B-cell compartment but no progressive disease Blood 2009; 114, (abstract #59).
10. Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982; 38: 933-942.
11. Hakulinen T, Abeywickrama KH. A computer program package for relative survival analysis. Comput Programs Biomed 1985; 19: 197-207. (Pubitemid 15098487)
12. Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 2002; 346: 564-569. (Pubitemid 34438817)